Key statistics
On Friday, Conduit Pharmaceuticals Inc (CDT:NMQ) closed at 0.139, 23.45% above the 52 week low of 0.1126 set on Sep 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.1302 |
---|---|
High | 0.1427 |
Low | 0.1281 |
Bid | 0.134 |
Offer | 0.1399 |
Previous close | 0.1337 |
Average volume | 2.15m |
---|---|
Shares outstanding | 96.00m |
Free float | 29.13m |
P/E (TTM) | -- |
Market cap | 13.34m USD |
EPS (TTM) | -0.0667 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
- Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
- Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
- Conduit Pharmaceuticals to Join Russell 3000® Index
- Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
- Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
- Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
- Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
More ▼